期刊文献+

耐药性与敏感性阿萨希毛孢子菌感染小鼠病死率的对比研究 被引量:1

The comparative analysis of the fatality rate of the mice infected by resistant or senstive T.asahii strains
下载PDF
导出
摘要 目的研究阿萨希毛孢子菌氟康唑体外诱导的耐药株与其亲本菌株的致病性差异。方法通过最低抑菌浓度(MIC)梯度浓度升高的方法诱导出对氟康唑耐药的环境株和临床株,不同菌株感染BALB/c小鼠,观察不同组小鼠病死率的差异。结果成功获得耐药表型稳定的耐药株(氟康唑MIC值>64 μg/ml),通过组织培养和活检组织病理确定建模成功。环境敏感组病死率为(57.50±3.54)%,环境耐药组病死率为(50.00±7.07)%,临床敏感组病死率为(77.50±3.54)%,临床耐药组病死率为(37.50±3.54)%。结论环境敏感株与环境氟康唑诱导的耐药株对小鼠的致病性无明显差异,而临床来源诱导的耐药株宿主体内致病性降低,具体机制需要后续进一步研究。 Objective To investigate the pathogenicity differences of parental T.asahii strains CBS8904,CBS2479 and the evolution T.asahii strains which were induced in vitro by fluconazole.Methods Two T.asahii strains,including an environmental isolate CBS8904 and a clinical isolate CBS2479,were subcultured with fluconazole in vitro by the minimum inhibitory concentration(MIC)gradient method,then the different T.asahii strains were used to infect BALB/c mice,and the fatality rate was evaluated.Results Resistant strains 8904R and 2479R were obtained successfully(MIC>64μg/ml).The fatality rates of CBS8904,8904R,CBS2479 and 2479R were(57.50±3.54)%,(50.00±7.07)%,(77.50±3.54)%and(37.50±3.54)%respectively.Conclusion There was no significant difference in pathogenicity between CBS8904 and 8904R,but the fatality rate of the infected mice by 2479R was significantly lower than that by CBS2479.
作者 彭卓颖 田艳丽 廖勇 郎德休 敖俊红 杨蓉娅 PENG Zhuo-ying;TIAN Yan-li;LIAO Yong(Institute of Damage and Repair,the Seventh Medical Center of PLA General Hospital,Beijing 100700,China)
出处 《实用皮肤病学杂志》 2019年第5期263-266,共4页 Journal of Practical Dermatology
基金 军队“十二五”重点课题项目(BWS11J059) 国家自然科学基金面上项目(81571972) 北京市科技新星项目(Z161100004916139)
关键词 阿萨希毛孢子菌 氟康唑 体外诱导耐药 病死率 Trichosporon asahii Fluconazole Induced-resistance»in vitro Fatality rate
  • 相关文献

参考文献4

二级参考文献67

  • 1阎澜,张军东,曹永兵,王彦,贾鑫明,姜远英.体外诱导白念珠菌对氟康唑耐药性的研究[J].药学服务与研究,2005,5(4):330-334. 被引量:4
  • 2周辉,龙铁军.Erg11基因突变与白念珠菌对唑类药物耐药性的初步研究[J].中国感染与化疗杂志,2007,7(2):108-110. 被引量:7
  • 3Ian M G,Jos W M.Antibiotic polices:theory and practice[M].New York:KluwerA cademic/Plenum Publishers,2005:312. 被引量:1
  • 4Hernandez S,Lopez-Ribot J L,Najvar L K,et al.Casopofungin resistance in Candida albicans:correlating clinical outcome with laboratory susceptibility testing of three isogenic isolates serially obtained fi om a patient with progressive Candida esophagitis[J].Antimicrob Agents Chemother,2004,48(4):1382-1383. 被引量:1
  • 5Laveriere M,Lalonde R G,Baril J G,et al.Progressive loss of echinocandin activity following prolonged use for treatment of Candida albicans oesophagitis[J].J Antimicrob Chemother,2006,57(4):705-708. 被引量:1
  • 6Krogh-Madsen M,Arendrup M C,Heslet L,et al.Amphotericin B and caspofungin resistance in Candida glabrata isolates recovered from a critically ill patient[J].Clin Infect Dis,2006,42(7):938-944. 被引量:1
  • 7Hakki M,Staab J F,Marr K A.Emergence of a Candida krusei isolate with reduced susceptibility to caspofungin during therapy[J].Antimicrob Agents Chemother,2006,50(7):2522-2524. 被引量:1
  • 8Pasquale T,Tomada J R,Ghannoun M,et al.Emergence of Candida tropicalis resistant to caspofungin[J].J Antimicrob Chemother,2008,61(1):219. 被引量:1
  • 9Park S,Kelly R,Kahn J N,et al.Specific substitutions in the echinocandin target Fks I p account for reduced susceptibility of rare laboratory and clinical Candida sp.isolates[J].Antimicrob Agents Chemother,2005,49(8):3264-3273. 被引量:1
  • 10Douglas C M,D'Ippolito J A,Shei G J,et al.Identification of the FKSI gene ofCandida albicans as the essential target of 1,3-β-D-glucan synthase inhibitors[J].Antimicrob Agents Chemother,1997,41 (11):2471-2479. 被引量:1

共引文献25

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部